Infinity Pharmaceuticals Shares Down 38.8% Since SmarTrend's Sell Call (INFI)

SmarTrend identified a Downtrend for Infinity Pharmaceuticals (NASDAQ:INFI) on February 3rd, 2015 at $14.14. In approximately 6 months, Infinity Pharmaceuticals has returned 38.83% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.